- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Burnette, J. M.
- Articles by Lopez, A. J.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Burnette, J. M.
- Articles by Lopez, A. J.
Trans-acting Factors Required for Inclusion of Regulated Exons in the Ultrabithorax mRNAs of Drosophila melanogaster
James M. Burnette1,a, Allyson R. Hatton1,a, and A. Javier Lopezaa Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, Pennyslvania 15213
Corresponding author: A. Javier Lopez, Department of Biological Sciences, Carnegie Mellon University, 4400 Fifth Ave., Pittsburgh, PA 15213., jlaa{at}andrew.cmu.edu (E-mail)
Communicating editor: L. L. SEARLES
| ABSTRACT |
|---|
Alternatively spliced Ultrabithorax mRNAs differ by the presence of internal exons mI and mII. Two approaches were used to identify trans-acting factors required for inclusion of these cassette exons. First, mutations in a set of genes implicated in the control of other alternative splicing decisions were tested for dominant effects on the Ubx alternative splicing pattern. To identify additional genes involved in regulation of Ubx splicing, a large collection of deficiencies was tested first for dominant enhancement of the haploinsufficient Ubx haltere phenotype and second for effects on the splicing pattern. Inclusion of the cassette exons in Ubx mRNAs was reduced strongly in heterozygotes for hypomorphic alleles of hrp48, which encodes a member of the hnRNP A/B family and is implicated in control of P-element splicing. Significant reductions of mI and mII inclusion were also observed in heterozygotes for loss-of-function alleles of virilizer, fl(2)d, and crooked neck. The products of virilizer and fl(2)d are also required for Sxl autoregulation at the level of splicing; crooked neck encodes a protein with structural similarities to yeast-splicing factors Prp39p and Prp42p. Deletion of at least five other loci caused significant reductions in the inclusion of mI and/or mII. Possible roles of identified factors are discussed in the context of the resplicing strategy for generation of alternative Ubx mRNAs.
ALTERNATIVE splicing of pre-mRNAs is a versatile regulatory mechanism that can achieve quantitative control of gene expression and functional diversification of gene products (reviewed by ![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Members of the SR family of RNA-binding proteins are required for multiple steps of the splicing reaction in vitro and their concentration can influence splice site competition both in vitro and in overexpression assays using cultured cells (reviewed in ![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Although a framework of hypotheses is evolving, we still know little about regulators of alternative splicing and how they function in vivo. Notable exceptions are SXL and TRA, proteins that control alternative splicing decisions during sex determination in Drosophila (reviewed in ![]()
![]()
![]()
![]()
![]()
![]()
We are using the homeotic gene Ultrabithorax (Ubx) of Drosophila melanogaster as a model for regulation of alternative splicing in large and complex transcription units. The six alternative Ubx mRNAs share large protein-coding 5' and 3' exons but differ in the pattern of incorporation of three elements: B is comprised between two alternative donor sites at the end of the first common exon, whereas mI and mII are internal cassette exons (Figure 1). Alternative isoforms that differ by the presence of mI and/or mII are expressed with different stage-, tissue-, and cell-specific profiles (![]()
![]()
![]()
![]()
![]()
![]()
![]()
|
Strong reductions of function for the postulated type of regulatory factors would probably cause lethal phenotypes that would be uninterpretable in terms of effects on Ubx splicing. On the other hand, the Ubx splicing pattern should be sensitive to partial reductions in the concentration or activity of these regulatory factors. This may also be true for factors that play important accessory roles in regulation as targets or as constitutively expressed components of regulatory complexes. We used two approaches to identify such factors. First, we tested whether the Ubx alternative splicing pattern is altered in heterozygotes for strong loss-of-function mutations in a set of genes implicated in the control of alternative splicing in Sxl and P-element RNAs. To identify the location of additional genes involved in regulation of Ubx splicing, we tested a large collection of deficiencies for dominant enhancement of the haploinsufficient Ubx haltere phenotype; then we asked whether the Ubx splicing pattern is altered in heterozygotes for the interacting deficiencies, and we traced the phenotypic interaction and effect on splicing to specific genes when mutations existed in reasonable candidates.
| MATERIALS AND METHODS |
|---|
Strains:
The wild-type reference strain was Oregon-R. The deficiency kit from the Drosophila Stock Center (Bloomington, IN) was used. Deficiencies that exhibited relevant interactions with Ubx are described in the text. A complete list of deficiencies tested is available upon request. Except as noted, all deficiencies and mutations were balanced using FM7c [In(1)FM7, y31d sc8 wa B, snX2 vOf, g4], CyO [In(2LR)O, Cy dplvI pr cn2], TM6B [In(3LR)TM6B, Hu e Tb], TM3 [In(3LR)TM3, ri pp sep l(3)89Aa bx34e e Sb], TM1 [In(3LR)TM1, Me ri sbdl), or MKRS [Tp(3;3)MKRS, M(3)76A kar ry2 Sb] (detailed descriptions in ![]()
Isolation of RNA:
For each genotype analyzed, total RNA was isolated from five late third instar female larvae, using the RNeasy reagents from QIAGEN (Chatsworth, CA). Larvae were grown on standard medium containing bromphenol blue (0.05%) to facilitate visualization of gut contents, and individuals within 15 min of pupariation were identified by their cleared intestinal tracts (![]()
![]()
Reverse transcription/amplification assays:
Reverse transcription primed with oligo(dT) was performed with 1 µg total RNA in a volume of 20 µl using Superscript II reverse transcriptase (GIBCO-BRL Life Technologies, Gaithersburg, MD). After treatment with RNAse H, 2 µl of the cDNA products were diluted to 50 µl and amplified with Display Taq-FL polymerase (PGC Scientific) using 10 pmol of each primer. To amplify Ubx cDNAs, the primers were Ubx.5S1 (5'-TGGAATGCCAATTGCACCATC-3'), which hybridizes to Ubx exon E5' at nucleotides -133 through -113 relative to 5' splice site "b," and Ubx.3A1 (5'-GCGGGTCAGATAATGATTCGT-3'), which hybridizes to nucleotides 78 through 98 relative to the 3' splice site of exon E3'. To amplify ras1 cDNAs as an internal standard, the primers were Ras1.5S1 (5'-GAGAGTAAGCATCGATCGCG-3') and Ras1.3A1 (5'-GGCGGATGTCTCAATGTATGG-3'). Amplification was performed in the presence of 5 µCi [
-32P]dCTP. The products were separated on a nondenaturing 8% polyacrylamide gel and quantitated on a Fuji BAS-2000 phosphorimager (Fuji Medical Systems USA/Bio Images, Stamford, CT) using MacBas image analysis software. The identities of the amplified Ubx cDNAs were confirmed by digestion with BglII and DdeI, which cleave in mI and mII, respectively. To ensure that the assays would accurately reflect the Ubx isoform ratios, we determined the extent of amplification of Ubx cDNAs and of the reference standard ras1 between 16 and 28 cycles of the polymerase chain reaction. Under our conditions for RNA isolation, reverse transcription and PCR, amplification of both ras1 and Ubx was exponential through the 26th cycle and the qualitative and quantitative aspects of the Ubx isoform pattern were highly reproducible within the same range. For subsequent experimental determinations, the quantitations of Ubx isoform ratios were performed on samples amplified through the 22nd cycle, which was well within the exponential range in all cases.
Screening protocol:
We reasoned that the tissue-specific Ubx splicing pattern should be sensitive to the zygotic dose of critical regulatory factors. To bias the screen toward identification of such factors, we focused on zygotic effects whenever this was practical. This strategy also helped to avoid problems due to masking of enhancers or suppressors by maternal effect modifiers with opposing effects, and it allowed us to identify clear correlations between inheritance of the mutant chromosome and modification of the Ubx phenotype. For deficiencies or mutations on the autosomes and for X-linked lesions balanced with X;Y translocations, males of the corresponding strain were mated to virgin females of genotypes Ubx195/MKRS and Ubx9.22/MKRS. For lethal X-linked lesions balanced in females, virgin females of the corresponding strain were mated to male Ubx195/MKRS and Ubx9.22/MKRS. Control crosses between Oregon-R and Ubx195/MKRS or Ubx9.22/MKRS were performed in the appropriate orientation for each case. Two sets of paired replicates were established for each cross and the phenotypes of progeny in each set were evaluated by different individuals without knowledge of the specific lesion being tested. The number of pigmented bristles along the anterior "margin," base, and hinge was recorded for each haltere on intact, living flies, and qualitative appraisals of relative haltere size and shape were made. At least 50 halteres (over 100 in most cases) were scored for each genotype. The set of mutant strains included a very weak Ubx allele [associated with Df(3R)C4] and several known suppressors and enhancers belonging to the Polycomb and trithorax groups as positive controls. All crosses were performed on standard molasses/cornmeal/agar/yeast medium at 25°.
Statistical analysis:
Data on bristle numbers and isoform ratios were analyzed using the Statistica software package (StatSoft, Tulsa, OK). There were no significant differences among the bristle counts recorded by different scorers when individual genotypes or the complete data set were considered. Bristle counts for experimental genotypes were compared with those of progeny from crosses to Oregon-R to identify cases of suppression or enhancement. A value of P < 0.01 (Student's t-test) was imposed as the upper limit for evidence of significant modification of the Ubx phenotype relative to the Oregon-R background.
| RESULTS |
|---|
Stability of the Ubx alternative splicing pattern:
We used coupled RT-PCR assays to analyze the pattern of Ubx alternative splicing in heterozygous third instar larvae and in adults. To minimize variations between strains due to differences in developmental rate, the larvae used for these experiments were staged to be within 15 min of pupariation by monitoring the clearing of bromphenol blue-containing medium from the gut (![]()
![]()
![]()
|
|
It is important to note that the Ubx isoform ratios did not vary significantly between different wild-type strains nor between these and several control strains that carried different balancer chromosomes and irrelevant mutations (Figure 2; Table 1). The Ubx isoform ratios were also unaltered in heterozygotes for various Minute mutations that cause dominant eye and bristle abnormalities and reductions in developmental rate, viability, and fertility (below and data not shown). These results demonstrate that the mechanism that controls Ubx alternative splicing is robust, a conclusion that is consistent with the faithful conservation of Ubx isoform structure and expression among Drosophila species spanning 60 million years of evolution (![]()
Although amplified Ubx cDNA fragments that contain mI but not mII (i.e., hypothetical isoforms IIIa and IIIb, as illustrated in Figure 1) would have the same length as isoforms IIa and IIb, such amplimers exhibit distinctly slower mobility due to the difference in nucleotide sequence (![]()
virilizer and fl(2)d are required for inclusion of mI and mII in Ubx mRNAs:
The products of Sxl, tra, and tra-2 are known regulators of alternative splicing decisions in Drosophila (reviewed in ![]()
![]()
![]()
![]()
In contrast to the stability described in the preceding section, the Ubx splicing pattern was altered significantly when the expression or function of virilizer or fl(2)d was reduced. The strongest effect was observed with virilizer, using a loss-of-function allele (vir3) that is recessive lethal in both sexes. In heterozygous larvae the proportion of Ubx class I mRNAs declined while that of classes II and IV increased (Table 2; Figure 3). The proportion of class I that contained the B element was not altered. The increase in classes II and IV indicates that inclusion of both mI and mII was reduced but that the effect on mI exceeded that on mII (see Figure 1). Inclusion of mI was also reduced in adults (Table 2), although the effect was weaker than in larvae. More modest but statistically significant reductions of mI and mII inclusion were also observed in larvae heterozygous for the fl(2)d2 mutation (Table 2), which is also a loss-of-function allele that is recessive lethal in both sexes. A null allele of l(2)49Db (TW6) had no significant dominant effect on the Ubx splicing pattern (Table 2).
|
|
hrp48 plays a critical role in the inclusion of mI and mII:
hrp48 is a member of the hnRNP-A/B family of RNA-binding proteins (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
|
Strategy to identify additional modifiers of the Ubx splicing pattern:
In heterozygotes for strong loss-of-function Ubx alleles the haltere is transformed weakly toward wing, exhibiting a slight increase in size and a small and variable number of bristles on the hinge, on the base, and on the region of the capitellum homologous to the anterior wing margin. The severity of this transformation increases with further reductions in Ubx function, for example, in heteroallelic combinations involving null and hypomorphic alleles. Several observations suggested that this phenotype might be enhanced by alterations in the Ubx splicing pattern. First, throughout development cells of the integument express UBX isoforms Ia/b (which contain exons mI and mII) and IIa/b (which contain exon mII) but not isoforms IVa/b, which lack exons mI and mII and are restricted to the central nervous system (![]()
![]()
![]()
and 0.9 [±0.9 (SD); N = 138] for
to 3.6 [±1.6 (SD); N = 50] and 2.6 [±1.5 (SD); N = 46] in the corresponding double heterozygotes with hrp481/+. These enhancements were highly significant (t-test, P < 0.001). The vir3 and fl(2)d2 mutations produced more modest enhancements of bristle number (~50% increase, P < 0.01) that were consistent with their weaker effects on Ubx splicing.
Other factors required for inclusion of mI and/or mII might exhibit similar genetic interactions with Ubx mutations. To identify such factors, we tested a collection of 196 deficiencies (collectively deleting ~85% of the euchromatic genome) for dominant modification of the haltere phenotype in Ubx195 or Ubx9.22 heterozygotes (see MATERIALS AND METHODS). We used both Ubx alleles to increase the versatility of the screen: depending on the degree to which the shift in splicing pattern reduces the function of the wild-type Ubx allele, factors required for mII inclusion might be identified as specific suppressors of Ubx195/+, as specific enhancers of Ubx9.22/+, or as enhancers of both. Suppressors of both genotypes are unlikely to reduce inclusion of mI and mII, because the function of the Ubx9.22 allele cannot be increased by alterations in the splicing pattern. Subsequently, we determined whether the Ubx splicing pattern was altered in animals that were homozygous wild type for Ubx but were heterozygous for appropriately interacting deficiencies. Where possible, we traced the phenotypic interaction and the effect on splicing to specific genes using existing mutations. As described below, effects on the Ubx splicing pattern were identified among differential modifiers as well as enhancers of the haltere phenotype.
Deficiencies that interact differentially with Ubx195 and Ubx9.22:
Only two deficiencies enhanced Ubx9.22/+ significantly (P < 0.01) but suppressed or had no significant effect on Ubx195/+, and these deficiencies overlapped (Table 3). RT-PCR analysis revealed that inclusion of mI and (as predicted) mII was reduced significantly in larvae heterozygous for Df(3R)l26c, although not in adults (Table 4). A qualitatively similar result was observed with Tp(3;Y)ry506-85C, although reduction of mI was stronger and was also observed in adults (data not shown). Both deficiencies delete the interval 87E187F11. Among the genes known to reside in this region, four encode widely expressed RNA-binding proteins that might influence processing or stability of Ubx RNAs: squid (sqd; encodes hrp40, related to the hnRNP A/B family; ![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
|
|
|
Common enhancers:
Forty deficiencies stood out for their strong enhancement of both Ubx195/+ and Ubx9.22/+; these effects consisted of an obvious increase in haltere size and a 4- to 18-fold enhancement in the average number of bristles per haltere that was significant at the P < 0.01 level (Table 6). A somewhat weaker enhancer, Df(2R)OR-BR6, deletes virilizer (located at 59D859D11), which was shown above to be required for inclusion of mI and mII. RT-PCR analysis confirmed that Df(2R)OR-BR6 produces a dominant reduction of mI and mII inclusion similar to that caused by vir3 in larvae and adults (data not shown).
|
crooked neck:
One enhancer, Df(1)64c18g, deletes the genes crooked neck (crn) and kurz (kz), which are located at 2F1 and are both candidate RNA-processing factors. The crn gene encodes a protein with 16 tetratrichopeptide repeats, a motif implicated in protein-protein interactions. Although CRN protein has been proposed to function as a transcription factor involved in cell cycle control (![]()
![]()
![]()
![]()
Unknown factors:
We defined priorities for detailed analysis of the remaining enhancers by excluding those deficiencies that delete genes known to be required for normal levels of transcription of Ubx and other homeotic genes. Among the remaining strong enhancers, we focused on cases where two or more overlapping deficiencies with similar effects defined a region likely to contain the interacting gene(s). These criteria defined eight distinct candidate regions (identified as paired deficiencies; see Table 6, footnote b). Both deficiencies covering each of these regions were tested by RT-PCR, and the results confirmed that deletion of two candidate regions altered the splicing pattern of Ubx mRNAs significantly (Table 4). The strongest effect was observed with Df(3L) Rdl-2 (deletes 66F5); this effect matched that of Df(3L)29A6 (deletes 66F5; 67B1; data not shown), confirming the location within 66F5 of genes required for inclusion of mI and mII. The effect of Df(2L)TW158 (deletes 37B2-8; 37E2-F4) matched that of Df(2L)TW203 (deletes 36E4-F1; 37B9-C1; data not shown), confirming that the region between 36E4 and 37C1 also contains genes required for inclusion of mI and mII. No significant effect on Ubx splicing was observed with overlapping deficiencies covering the regions 65F3 through 66B10, 70D1 through 71E4-5, 71F1-4 through 73A3-4, or 85D8-12 through 85F16 (Table 4; data not shown). Df(3R)crb87-4 (deletes 95E8-F1; 95F15) had a weak effect on mI but this was not exhibited by Df(3R)crb87-5 (deletes 95F7; 96A17-18; data not shown), suggesting that the relevant locus is between 95E8 and 95F7.
The last case is more complicated. RT-PCR experiments showed extremely variable effects of Df(3R)M-Kx1 (deletes 86C1; 97B5) on Ubx splicing, ranging from almost complete exclusion of all three differential elements (two independent experiments, not included in Table 4) to subtle reduction of mII inclusion (Table 4). This variability may be due to the presence of additional strong modifiers in the genetic background. Df(3R)M-Kx1 and Df(3R)M86D have dominant Minute phenotypes that may have favored the accumulation of modifiers that improve viability, fertility, or developmental rate. The effect of Df(3R)M-Kx1 on Ubx splicing decreased upon extensive outcrossing, suggesting that it is caused or enhanced strongly by such modifiers. Df(3R)M86D (deletes 86D1; 86D4) produced no obvious change in the splicing pattern, but it has not been tested after extensive outcrossing. The gene for a Drosophila SR protein, Rbp1, has been mapped to region 86D by in situ hybridization (![]()
![]()
| DISCUSSION |
|---|
We have conducted a partial survey of the Drosophila genome to identify genes with zygotic haploinsufficient effects on alternative splicing of Ubx mRNAs. These experiments have identified four specific factors and at least five regions that contain additional genes required for inclusion of exons mI and mII in Ubx mRNAs. In contrast to the effects of these mutations and deficiencies, null mutations in many other known or suspected splicing factors had no haploinsufficient effect on the Ubx phenotype or alternative splicing pattern; in addition to factors described above (the SR protein B52; the hnRNP-A/B-like proteins hrp40 and Hrb87F), this also included components of the basic splicing machinery (U2AF-38; SNF, which is a component of the U1- and U2-snRNPs), other factors implicated in control of splicing (Suppressor-of-sable and Suppressor-of-wa), and other hnRNP proteins (hnRNP-L, encoded by smooth; ![]()
An important feature of our approach is that splicing of Ubx RNAs was not compromised in any way to sensitize the screen. The Ubx195 mutation does not affect splice sites nor the splicing process, and Ubx9.22 is null because of deletion of essential protein sequences, so that enhancement of Ubx9.22/+ must result from effects on expression or function of the wild-type allele. Furthermore, the RT-PCR experiments that revealed effects on splicing of Ubx RNAs were performed on larvae and adults whose Ubx genotypes were wild type for both alleles. Thus, all effects reported here reflect the sensitivity of the natural Ubx transcript to reductions in factors that are required for its correct processing during development.
Together, these considerations suggest strongly that the genes we have identified play important roles in the regulation of Ubx splicing by encoding regulatory factors, cofactors, or targets.
Possible roles of trans-acting factors:
The inclusion of mI and mII in Ubx mRNAs is regulated by competition between 5' splice sites that flank each of these exons after they are joined to E5' (![]()
Reduction of function in all of the factors identified in this work leads to reduced inclusion of mI (and in most cases also mII). This suggests roles in suppression of the upstream sites (which strongly match the 5' splice site consensus) or stimulation of the downstream sites (which match the consensus more weakly). It is interesting that three of the factors identified in this study that are required for inclusion of mI and mII in Ubx mRNAs may also be required for suppression of 5' splice site utilization in other RNAs: the functions of virilizer and fl(2)d are required for SXL to repress splicing of the male-specific exon in its own RNA (![]()
![]()
![]()
![]()
![]()
The products of virilizer, fl(2)d, and snf might function as parts of a complex that mediates active repression of 5' splice site utilization through interactions with U1 snRNP. Formation or stabilization of this repression complex could be directed to different target splice sites through the action of distinct factors that, like SXL, bind to cis-acting regulatory signals and interact with components of the complex. A direct interaction between SXL and SNF to mediate 5' and 3' splice site repression in Sxl RNA has been proposed on the basis of genetic interactions, coimmunoprecipitation in RNA-dependent complexes from Drosophila extracts, and physical association of recombinant proteins in vitro (![]()
![]()
![]()
![]()
![]()
![]()
An intriguing possibility is that hrp48 interacts (directly or indirectly) with a U1 snRNP/SNF/VIR/FL(2)D complex to target suppression of splicing at the upstream sites that are used to remove mI. The strong reduction of mI inclusion (27%) observed in hrp481 heterozygotes suggests a critical role for hrp48 in modulating competition between the regenerated and downstream 5' splice sites that flank this exon. Although hrp48 is an hnRNP protein that probably binds nonspecifically to many RNAs, it is also known to form part of a specific complex that blocks use of the 5' splice site for the third intron of P-element RNA in somatic cells (![]()
![]()
![]()
![]()
The effect of hrp48, vir, and fl(2)d mutations on inclusion of exon mII, which does not contain an F2-like element, may not be the result of resplicing at the E5'/mII junction. The reduction of mII inclusion (detected as an increase in class IV mRNAs rather than a decrease in class II) could be explained if the repression complex must remain assembled at the E5'/mI junction to prevent subsequent removal of mI and mII together during splicing of intron 3. Intermediates from which mI is removed during splicing of intron 2 would retain mII. The net result would be an increase in both class II and class IV mRNAs, as observed.
In addition, we note that the effect of hrp48 mutations on mI and mII inclusion is the opposite of what one would expect from the simple idea that hnRNP A/B proteins generally promote exon skipping (and use of upstream 5' splice sites), antagonizing a general effect of SR proteins that promote exon inclusion (or use of downstream 5' splice sites) (reviewed in ![]()
![]()
It is more difficult to speculate on the roles of crn or the still-unidentified factors deleted by deficiencies that alter the Ubx splicing pattern. In principle, these could participate in repression of the regenerated 5' splice sites or stimulation of the competing downstream site. They could also be involved in interactions between mI and mII that seem to be required for effective use of the downstream 5' splice site located at the mI/intron 2 boundary (![]()
![]()
![]()
Additional observations in our laboratory indicate that inclusion of mI is controlled by a complex regulatory switch employing multiple factors to balance positive and negative inputs acting on the upstream and perhaps downstream splice sites (![]()
![]()
![]()
![]()
![]()
![]()
Additional factors:
It is unlikely that the factors described here represent all of those with critical effects on Ubx splicing regulation. The analysis of deficiencies itself poses certain limitations: an effect on the Ubx haltere phenotype may be masked by the simultaneous deletion of a gene that encodes a negative regulator of Ubx expression or function or of two factors with opposite effect on the regulation of Ubx splicing. Furthermore, we have performed detailed molecular analyses by quantitative RT-PCR only for those regions whose phenotypic interactions with Ubx were confirmed by overlapping deficiencies, but another 22 regions were tentatively identified by single deficiencies as containing strong haploinsufficient enhancers of Ubx and might harbor genes with important effects on splicing; thus the regions described above are probably only a subset of those that can be identified with this approach. Using the positional information provided by the deficiencies plus RT-PCR assays of the Ubx splicing pattern, it should be possible to identify specific mutations in the relevant gene(s) within any region of interest.
| FOOTNOTES |
|---|
1 These authors contributed equally to this work. ![]()
| ACKNOWLEDGMENTS |
|---|
We thank Collin Bachert for preparation of media and assistance with fly husbandry. We thank Steven Mount, Norbert Perrimon, Donald Rio, and Helen Salz for mutant strains and for sharing unpublished data. A.H. was the recipient of a predoctoral fellowship under the Training Program in Computational, Cell, and Developmental Biology in the National Science Foundation Science and Technology Center for Light Microscope Imaging and Biotechnology. This work was supported by Public Health Service research grants RO1-HD28664 and K02-HD01155 (to A.J.L.).
Manuscript received October 2, 1998; Accepted for publication January 20, 1999.
| LITERATURE CITED |
|---|
ADAMS, M. D., R. S. TARNG, and D. C. RIO, 1997 The alternative splicing factor PSI regulates P-element third intron splicing in vivo. Genes Dev. 11:129-138
ASHBURNER, M., 1989 Drosophila: A Laboratory Handbook. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
BERGET, S. M., 1995 Exon recognition in vertebrate splicing. J. Biol. Chem. 270:2411-2414
BLACK, D. L., 1995 Finding splice sites in a wilderness of RNA. RNA 1:763-771[Medline].
BOMZE, H. M. and A. J. LOPEZ, 1994 Evolutionary conservation of the structure and expression of alternatively spliced Ultrabithorax isoforms from Drosophila.. Genetics 136:965-977[Abstract].
CÁCERES, J. F., and A. R. KRAINER, 1997 Mammalian pre-mRNA splicing factors, pp. 174212 in Eukaryotic mRNA Processing, edited by A. R. KRAINER. IRL Press, Oxford.
CHABOT, B., 1996 Directing alternative splicing: cast and scenarios. Trends Genet. 12:472-478[Medline].
CHAMPLIN, D. T., M. FRASCH, H. SAUMWEBER, and J. T. LIS, 1991 Characterization of a Drosophila protein associated with boundaries of transcriptionally active chromatin. Genes Dev. 5:1611-1621
CLINE, T. W. and B. J. MEYER, 1996 Vive la difference: males vs females in flies vs worms. Annu. Rev. Genet. 30:637-702[Medline].
COOPER, T. A. and W. MATTOX, 1997 The regulation of splice-site selection, and its role in human disease. Am. J. Hum. Genet. 61:259-266[Medline].
DESHPANDE, G., M. SAMUELS, and P. SCHEDL, 1996 Sex-lethal interacts with splicing factors in vitro and in vivo. Mol. Cell. Biol. 16:5036-5047[Abstract].
FU, X.-D., 1995 The superfamily of arginine/serine-rich splicing factors. RNA 1:663-680[Medline].
GRABOWSKI, P. J., 1998 Splicing regulation in neurons: tinkering with cell-specific control. Cell 92:709-712[Medline].
GRANADINO, B., A. SAN JUAN, P. SANTAMARIA, and L. SANCHEZ, 1992 Evidence of a dual function in fl(2)d, a gene needed for Sex-lethal expression in Drosophila melanogaster.. Genetics 130:597-612[Abstract].
GRANADINO, B., L. O. PEÑALVA, and L. SANCHEZ, 1996 The gene fl(2)d is needed for the sex-specific splicing of transformer pre-mRNA but not for double-sex pre-mRNA in Drosophila melanogaster.. Mol. Gen. Genet. 253:26-31[Medline].
HAMMOND, L. E., D. Z. RUDNER, R. KANAAR, and D. C. RIO, 1997 Mutations in the hrp48 gene, which encodes a Drosophila heterogeneous nuclear ribonucleoprotein particle protein, cause lethality and developmental defects and affect P-element third intron splicing in vivo. Mol. Cell. Biol. 17:7260-7267[Abstract].
HATTON, A. R., V. SUBRAMANIAM, and A. J. LOPEZ, 1998 Processing of a large transcription unit: generation of alternative Ultrabithorax isoforms and stepwise removal of a large intron by regulated resplicing at exon-exon junctions. Mol. Cell. 2:787-796[Medline].
HAYNES, S. R., D. JOHNSON, G. RAYCHAUDHURI, and A. L. BYER, 1991 The Drosophila Hrb87F gene encodes a new member of the A and B hnRNP protein group. Nucleic Acids Res. 19:25-31
HAYNES, S. R., M. T. COOPER, S. PYPE, and D. S. STOLOW, 1997 Involvement of a tissue-specific RNA recognition motif protein in Drosophila spermatogenesis. Mol. Cell. Biol. 17:2708-2715[Abstract].
HEINRICHS, V. and B. S. BAKER, 1995 The Drosophila SR protein RBP1 contributes to the regulation of doublesex alternative splicing by recognizing RBP1 RNA target sequences. EMBO J. 14:3987-4000[Medline].
HEINRICHS, V., L. C. RYNER, and B. S. BAKER, 1998 Regulation of sex-specific selection of fruitless 5' splice sites by transformer and transformer-2.. Mol. Cell. Biol. 18:450-458
HILFIKER, A., H. AMREIN, A. DUBENDORFER, R. SCHNEITER, and R. NOTHIGER, 1995 The gene virilizer is required for female-specific splicing controlled by Sxl, the master gene for sexual development in Drosophila. Development 121:4017-4026[Abstract].
KELLEY, R. L., 1993 Initial organization of the Drosophila dorsoventral axis depends on an RNA-binding protein encoded by the squid gene. Genes Dev. 7:948-960
KIM, Y. J., P. ZUO, J. MANLEY, and B. S. BAKER, 1992 The Drosophila RNA-binding protein RBP1 is localized to transcriptionally active sites of chromosomes and shows a functional similarity to human splicing factor ASF/SF2. Genes Dev. 6:2569-2579
KORNFELD, K., R. B. SAINT, P. A. BEACHY, P. J. HARTE, and D. A. PEATTIE et al., 1989 Structure and expression of Ultrabithorax mRNAs generated by alternative splicing and polyadenylation in Drosophila. Genes Dev. 3:243-258
KRÄMER, A., 1996 The structure and function of proteins involved in mammalian pre-mRNA splicing. Annu. Rev. Biochem. 65:367-409[Medline].
LINDSLEY, D. L., and G. ZIMM, 1992 The Genome of Drosophila melanogaster. Academic Press, New York.
LOPEZ, A. J., 1995 Developmental role of transcription factor isoforms generated by alternative splicing. Dev. Biol. 172:396-411[Medline].
LOPEZ, A. J., 1998 Alternative splicing of pre mRNA: developmental consequences and mechanisms of regulation. Ann. Rev. Genet. 32:279-305[Medline].
LOPEZ, A. J. and D. S. HOGNESS, 1991 Immunochemical dissection of the Ultrabithorax homeoprotein family in Drosophila melanogaster.. Proc. Natl. Acad. Sci. USA 88:9924-9928
LOPEZ, A. J., R. D. ARTERO, and M. PEREZ-ALONSO, 1996 Stage, tissue, and cell specific distribution of alternative Ultrabithorax mRNAs and protein isoforms in the Drosophila embryo. Roux's Arch. Dev. Biol. 205:450-459.
LYNCH, K. W. and T. MANIATIS, 1996 Assembly of specific protein complexes on distinct regulatory elements of the Drosophila doublesex splicing enhancer. Genes Dev. 10:2089-2101
MACDOUGALL, C., D. HARBISON, and M. BOWNES, 1995 The developmental consequences of alternative splicing in sex determination and differentiation in Drosophila. Dev. Biol. 172:353-376[Medline].
MANLEY, J. L. and R. TACKE, 1996 SR proteins and splicing control. Genes Dev. 10:1569-1579
MARONI, G. and S. C. STAMEY, 1983 Use of blue food to select synchronous, late third-instar larvae. Dros. Inf. Service 59:142-143.
MATUNIS, E. L., M. J. MATUNIS, and G. DREYFUSS, 1992 Characterization of the major hnRNP proteins from Drosophila melanogaster.. J. Cell Biol. 116:257-269
MCLEAN, M. R. and B. C. RYMOND, 1998 Yeast pre-mRNA splicing requires a pair of U1 snRNP-associated tetratrichopeptide repeat proteins. Mol. Cell. Biol. 18:353-360
O'CONNOR, M. B., R. BINARI, L. A. PERKINS, and W. BENDER, 1988 Alternative products from the Ultrabithorax domain of the bithorax complex. EMBO J. 7:435-445[Medline].
PENG, X. and S. M. MOUNT, 1995 Genetic enhancement of RNA-processing defects by a dominant mutation in B52, the Drosophila gene for an SR protein splicing factor. Mol. Cell. Biol. 15:6273-6282[Abstract].
REED, R., and L. PALANDJIAN, 1997 Spliceosome assembly, pp. 103129 in Eukaryotic mRNA Processing, edited by A. R. KRAINER. IRL Press, Oxford.
RING, H. Z. and J. T. LIS, 1994 The SR protein B52/SRP55 is essential for Drosophila development. Mol. Cell. Biol. 14:7499-7506
ROTH, M. B., A. M. ZAHLER, and A. M. STALK, 1991 A conserved family of nuclear phosphoproteins localized to sites of polymerase II transcription. J. Cell Biol. 115:587-596
SALZ, H. K. and T. W. FLICKINGER, 1996 Both loss-of-function and gain-of-function mutations in snf define a role for snRNP proteins in regulating sex-lethal Pre-mRNA splicing in Drosophila development. Genetics 144:95-108[Abstract].
SAMUELS, M., G. DESHPANDE, and P. SCHEDL, 1998 Activities of the sex-lethal protein in RNA binding and protein:protein interactions. Nucleic Acids Res. 26:2625-2637



